— Signal history
VERU alerts
Every time Stock Pulse flagged VERU in real time — with the full post-mortem behind each alert.
1alert
+58%best run
+58%median peak
-9%worst close
Healthcare · Biotechnology
Veru Inc.
Veru is the drug developer behind enobosarm, which its Phase 2b PLATEAU trial tests against the muscle loss that comes with GLP-1 drugs.
Cap~$36M / float: 13.7M
Day volume92.9M (~7x the float)
Prev close$2.25 — no gap, this all happened mid-session
52w range$2.05–$7.40, and the peak nearly tagged the high
Snapshot from the Jun 4, 2026 post-mortem.
